INTRODUCTION
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca, is 'a multifactorial disease of the tears and ocular surface, which results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface' [1] . Epidemiologic studies report the prevalence to be between 7% and 34% and increased with age; the highest prevalence reported came from a study of persons over age 65 [2] [3] [4] [5] [6] [7] [8] . DES can result from many causes, which will be discussed below. Conservative treatments, such as artificial tears, topical cyclosporine, punctal occlusion, and topical corticosteroids are the typical treatments for patients with dry eye syndrome [9] . In more advanced cases, autologous serum tears, scleral lenses, or surgical intervention can be considered.
SCLERAL LENS BACKGROUND
Use of scleral lenses was limited until 1983, when rigid gas permeable material was introduced into their design, which resolved the common problem of hypoxia [9,10 && ]. Throughout the 1980s and 1990s, scleral lenses were used primarily for corneal ectasia. As manufacturing capabilities and technology have expanded, use of scleral lenses has become increasingly common, and they are now widely used for treatment of ocular surface disease.
There are several ways to categorize scleral lenses. Traditionally, scleral lenses have been classified based on diameter: semi-scleral (13.6-14.9 mm), mini-scleral (15.0 -18.0 mm), and full-scleral (18.1-24.0þ mm) [11] . The Scleral Lens Education Society has recently recommended a new nomenclature based on size and fit characteristics of the lens relative to the eye [12] . According to this system, the most important aspect of a lens is whether it rests on the cornea, the sclera, or if it contacts both surfaces. A lens that rests entirely on the sclera is considered a scleral lens regardless of diameter.
Regardless of the nomenclature used, there are many manufacturers and designs of scleral lenses. According to the updated listing provided by the Gas Permeable Lens Institute, there are 18 manufacturers of commercially available scleral lenses in the United States offering 41 different lenses, with many available in a range of sizes (Table 1) [13] .
Treatment with scleral lenses may be indicated in a number of ocular surface diseases, including graftversus-host disease, Sjögren syndrome, StevensJohnson syndrome (SJS), and exposure keratopathy [10 && ]. However, it is important to recognize that indications continue to expand and include causes separate from ocular surface disease, such as corneal ectasia [10 && ]. Evaluation of DES and consideration for scleral lenses involve elements of the patient's medical and ocular history, ocular exam, and ancillary tests (Table 2 ). Previous ocular treatments for dry eye disease can be used as a marker for duration and severity of disease. History of glaucoma surgery should be noted so that lenses may be adjusted for presence of glaucoma filters and glaucoma drainage devices. Symptoms of DES can be evaluated with the ocular surface disease index (OSDI) and overall visual function can be assessed with the National Eye Institute Visual Function Questionnaire (NEI VFQ-25). A complete ocular exam, including staining with fluorescein, should be completed to look for characteristic staining pattern. Schirmer's test can help quantify degree of tear production. Topography has limited utility because scleral lenses vault the cornea [14] .
Most scleral lenses are fit through the use of inoffice diagnostic trial lens sets to best determine the initial scleral lens. Final lenses are selected based on evaluation of corneal vault, limbal clearance, and evaluation of peripheral fit to ensure there is no compression or impingement of scleral vasculature ( Fig. 1) . Some practitioners instill fluorescein before applying the scleral lens to help assess corneal vault, and many practitioners use fluorescein staining after removal of the scleral lens to ensure the lens is not leaving an impression in the conjunctiva. The power of the lens is determined via spherical overrefraction because corneal astigmatism is negated by the fluid reservoir. In some cases, residual cylinder can be incorporated through the use of front surface toric designs.
The anatomy of the sclera and cornea presents challenges to fitting scleral lenses. Anterior segment optical coherence tomography (OCT) data suggests that eyes are asymmetric [15, 16] . Asymmetric lenses such as back surface toric and quadrant specific lenses help achieve optimal fit. Recently, some practitioners have begun using anterior segment OCT to aid fit assessment [17, 18] . This technology can aid in the fitting process so that lenses closely match the patient's eye [16] . Although this technology has promising features, using trial lenses is still the most common fitting technique [19 && ,20] . In addition, wavefront-guided optics, although not widely available, may enhance visual outcomes [21, 22] .
Patients should be monitored at least annually, and can be considered for a re-fitting if there are any complications resulting from poor fit. The most common such complications to examine for are as follows: impaired vascular flow (impingement) (Fig. 2) ; reduction in corneal vault that can result from the lens settling over time; corneal edema because of tight fit; and in some cases conjunctival keratinization.
OUTCOMES
Outcomes of scleral lens efficacy can be measured in different ways, including validated symptom evaluation using OSDI and NEI-VFQ 25, functional performance including visual acuity, and independently designed questionnaires. Scleral lens use in DES has been shown consistently to have beneficial effects on patient comfort and visual function. In almost all studies reviewed, consisting of both case reports with small sample sizes and larger retrospective chart reviews, scleral lens wearers had improved OSDI and VFQ scores, and significantly improved visual acuity. Many of the studies report on a cohort of patients with ocular surface disease of different causes [20,23-27,28 & 
,29
& ], although some report strictly on specific primary conditions, including exposure keratopathy [30] [31] [32] , graft-versus-host disease [33] [34] [35] [36] , SJS [37, 38] [40 & ]. There are no appreciable differences in outcomes based on the cause of DES. The amount of time the patient wears the lens is another important outcome, and reports indicate patients wear their lenses for an average of over 16 h per day, nearly the goal of all waking hours [41] .
Some reports describe the features that were most correlated with good outcomes. The height of the corneal vault was found to be one of the important predictors; 0.2-0.3 mm was considered optimal [20] . Other important factors included 0.1 mm of limbal clearance, and lack of trapped
KEY POINTS
In patients with dry eye syndrome in whom traditional treatments have limited efficacy, scleral lenses are a well tolerated and efficacious treatment option.
Most reports of scleral lens use in dry eye syndrome cite improved visual acuity and relief of symptoms.
There are many different manufacturers of scleral lenses, and different styles of lenses, fitting techniques, and technologies used to assist fitting. air bubbles, which can result from imperfect fit or poor insertion technique [20] . Furthermore, good outcomes may be achieved in patients using autologous serum tears together with scleral lenses [42] , although there has not been a comparison of scleral lens use with and without autologous serum.
LENS APPLICATION AND CARE
Scleral lenses completely vault the cornea creating a liquid bandage that relieves DES symptoms. Therefore, sterile saline is used to fill the lens before insertion. Solutions most commonly used in the USA are Unisol-4 (Alcon), which is pH buffered for ophthalmologic use. In addition, some practitioners recommend 0.9% NaCl sterile inhalation vials. For insertion, the lens should be completely filled with the solution, the patient's face positioned parallel with the plane of the lens, and the lens held with the patient's fingers or a plunger [43] . If air bubbles become trapped under the lens during insertion, the lens should be removed, refilled with solution, and re-inserted. Removal of the lens, similarly, can be achieved with the patient's fingers or a plunger. It is important that patients are trained in proper insertion and removal techniques, as many FIGURE 1. This image shows a scleral lens fitting appropriately in an eye. There is no sign of compromised blood flow, as vessels peripheral and central to the lens are patent.
FIGURE 2. This image shows a poorly fit scleral lens in an eye. This lens fits tight on the sclera, resulting in vessel compression. Note the lack of blood flow immediately inferior to the lens.
patients experience difficulty with these steps. One report noted that 20% of scleral lens wearers complained of difficulty with placement of lenses, which likely contributed to discontinuation of use [44] . Cleaning and nightly disinfection can vary among practitioners but is generally similar to rigid gas permeable lens care and cleaning. Alcohol-based solutions are most often used for cleaning, whereas general contact lens storage solutions or hydrogen peroxide solutions may be used nightly for disinfection and storage purposes [43] .
COMPLICATIONS
Complications from scleral lens use are considered rare and mostly minor. Visual acuity can decrease after several hours of wear, likely because of trapped debris underneath the lens [45] . This problem can be remedied by removing lenses frequently, rinsing, and re-inserting [46] .
Conjunctival prolapse, a condition in which loose conjunctiva folds over the cornea because of pressure from the lens, has been described, but its incidence and ramifications are unknown [47] . A review of over 300 scleral lens wearers published in 1995 reported that the most common complications of scleral lens use are corneal neovascularization (13.3% of scleral lens wearers), corneal edema (7.4%), corneal abrasion (3.1%), and giant papillary conjunctivitis (1.7%) [48] , although the lenses and fitting procedures have undergone significant improvement since then. In addition to these complications, there have been case reports of infections in scleral lens wearers, including acanthamoeba keratitis [49 & ] and polymicrobial and microsporidial infections [50] .
CONCLUSION
Scleral lenses are well tolerated and efficacious for use in DES, and have been shown to improve symptoms and visual acuity while having few complications. Fitting and manufacturing techniques continue to improve and thus have improved patient access to scleral lens therapy. Optimal fit characteristics have been described and include 0.2-0.3 mm of corneal vault height and lack of trapped air bubbles. Scleral lenses should be considered for use in cases of severe DES alongside more aggressive treatment options. Further research is needed to compare the many different lenses currently available and to assess optimal fitting strategies as new assistive technologies become available.
